// App-Quantinova.ai

: Clinically Meaningful Improvement in Total Rhinoconjunctivitis Score with Olopatadine/mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis

Researchers

Presenter

  • Eli O Meltzer

Principal Investigators

  • Wen Wu

  • Anne Deen Christensen

  • Jane Wheeler

  • Vineet Aggarwal

  • Cynthia Caracta

Medical Centers

  • Glenmark Pharmaceutical, Watford, WD18 9YA, United Kingdom

  • Glenmark Pharmaceutical INC, Mahwah, NJ, United States of America

  • Glenmark Pharmaceuticals Ltd, Mumbai, India

  • Allergy and Asthma Medical Group and Research Center, San Diego, CA, United States of America

  • Seqirus, Melbourne, VIC, Australia

Locations

  • United States

  • India

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

Disease

  • Allergic rhinitis

Biomarkers

  • N/A

Drug/Treatment

  • Olopatadine hydrochloride

  • Mometasone furoate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved